Califf On Getting Someone Younger Than 70 To Take FDA Commissioner Job
Executive Summary
Robert Califf says there is a reason there is such a high turnover in the top post. He notes that the continuity and dedication of center directors is one of the reasons he returned.
You may also be interested in...
Biden Requests US FDA Budget Surge: Pandemic Preparedness Money Would Increase Funding 36%
President Biden’s budget request would add $1.63bn in mandatory funding to the FDA budget in FY 2023.
US FDA CDER, CBER Staff Say Pandemic Had Negative Effect On Hiring, Retention
Human resource managers also worried that since universal teleworking was valued by employees, a return to pre-pandemic conditions could cause a mass exodus.
Dr. Califf Returns To US FDA: What To Do First?
Acting commissioner Janet Woodcock will remain at the agency and become principal deputy commissioner when Califf arrives.